Equity Capital Markets, Financing

nCino, Inc.

10/20
|
$482.0 Million
Piper Sandler served as bookrunner for nCino, Inc. on a follow-on offering
Sub-Type
Follow-On Offering
Sector
Financial Services



Sub-Sector
FinTech

Related Transactions

All Transactions
$30.0 Million
milestone
Milestone Pharmaceuticals, Inc.
Confidentially Marketed Follow-On Offering
Left Bookrunner
$172.4 Million
Praxis
Praxis Precision Medicines
Confidentially Marketed Follow-On Offering
Active Bookrunner
$150.0 Million
Catalyst
Catalyst Pharmaceuticals, Inc.
Confidentially Marketed Follow-On Offering
Active Bookrunner
$161.0 Million
Keros
Keros Therapeutics
Confidentially Marketed Follow-On Offering
Active Bookrunner
$410.0 Million
NB
The Needham Bank
Initial Public Offering
Sole Marketing Agent
$115.1 Million
Ocular
Ocular Therapeutix, Inc.
Confidentially Marketed Follow-On Offering
Active Bookrunner
$747.5 Million
Merit
Merit Medical Systems, Inc.
Convertible Offering
Active Bookrunner
$632.9 Million
Super
Super Micro Computer, Inc.
COnfidentially Marketed Follow-On Offering
Passive Bookrunner
$175.3 Million
Skyward
Skyward Specialty Insurance
Follow-On Offering
Active Bookrunner
$733.6 Million
CCC
CCC Intelligent Solutions Holdings Inc.
Confidentially Marketed Follow-On Offering
Active Bookrunner
$300.0 Million
Navalent
Nuvalent, Inc.
Follow-On Offering
Active Bookrunner
Scholar
Scholar Rock Holding Corporation
Confidentially Marketed Follow-On Offering
Active Bookrunner
$1.5 Billion
Birkenstock
Birkenstock Holding plc
Initial Public Offering
Co-Manager
$63.2 Million
ALX
ALX Oncology
Confidentially Marketed Follow-On Offering
Active Bookrunner
$258.7 Million
Biohaven Ltd.
Confidentially Marketed Follow-On Offering
Active Bookrunner
$499.9 Million
Magrigal
Madrigal Pharmaceuticals, Inc.
Confidentially Marketed Follow-On Offering
Active Bookrunner

© 2024 Piper Sandler Companies. Since 1895. All rights reserved.